157 related articles for article (PubMed ID: 38277053)
1. Correction to: Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance.
De Leo A; Ruscelli M; Maloberti T; Coluccelli S; Repaci A; de Biase D; Tallini G
Virchows Arch; 2024 Feb; 484(2):321. PubMed ID: 38277053
[No Abstract] [Full Text] [Related]
2. Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance.
De Leo A; Ruscelli M; Maloberti T; Coluccelli S; Repaci A; de Biase D; Tallini G
Virchows Arch; 2024 Feb; 484(2):289-319. PubMed ID: 38108848
[TBL] [Abstract][Full Text] [Related]
3. Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors.
Wang GG; Yao JC; Worah S; White JA; Luna R; Wu TT; Hamilton SR; Rashid A
Mod Pathol; 2005 Aug; 18(8):1079-87. PubMed ID: 15920555
[TBL] [Abstract][Full Text] [Related]
4. Overview of Genetically Determined Diseases/Multiple Endocrine Neoplasia Syndromes Predisposing to Endocrine Tumors.
Decmann A; Patócs A; Igaz P
Exp Suppl; 2019; 111():105-127. PubMed ID: 31588530
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase A alterations in endocrine tumors.
Yu B; Ragazzon B; Rizk-Rabin M; Bertherat J
Horm Metab Res; 2012 Sep; 44(10):741-8. PubMed ID: 22752956
[TBL] [Abstract][Full Text] [Related]
6. Insights Obtained from the Nontumorous Glandular Tissue in Patients with Endocrine Tumors.
Tischler AS; LiVolsi VA; Asa SL
Endocr Pathol; 2023 Dec; 34(4):393-405. PubMed ID: 36943629
[TBL] [Abstract][Full Text] [Related]
7. [Endocrine tumors of the pancreas: classification, clinical and molecular prognostic factors].
Terris B
Ann Pathol; 2002 Oct; 22(5):367-74. PubMed ID: 12483154
[TBL] [Abstract][Full Text] [Related]
8. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
Fanburg-Smith JC; Furlong MA; Childers EL
Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing analysis suggests varied multistep mutational pathogenesis for endocrine mucin-producing sweat gland carcinoma with comments on INSM1 and MUC2 suggesting a conjunctival origin.
Mathew JG; Bowman AS; Saab J; Busam KJ; Nehal K; Pulitzer M
J Am Acad Dermatol; 2022 May; 86(5):1072-1079. PubMed ID: 33515627
[TBL] [Abstract][Full Text] [Related]
10. Salivary gland tumors: A 13-year clinicopathologic retrospective study in a Brazilian northeast population.
Cunha JL; Fraga VR; de Lima WP; Andrade AO; Gordón-Núñez MA; Nonaka CF; Alves PM; Júnior RA
J Clin Exp Dent; 2023 Feb; 15(2):e88-e95. PubMed ID: 36911148
[TBL] [Abstract][Full Text] [Related]
11. SALIVARY TUMORS. CLINICOPATHOLOGIC REVIEW OF 190 PATIENTS.
VANDENBERG HJ; KAMBOURIS A; PRYZYBYLSKI T; RACHMANINOFF N
Am J Surg; 1964 Oct; 108():480-4. PubMed ID: 14211434
[No Abstract] [Full Text] [Related]
12. The pathology of head and neck tumors: salivary glands, part 1.
Batsakis JG; Regezi JA
Head Neck Surg; 1978; 1(1):59-68. PubMed ID: 756396
[TBL] [Abstract][Full Text] [Related]
13. Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors).
Oberg K
Curr Opin Endocrinol Diabetes Obes; 2009 Feb; 16(1):72-8. PubMed ID: 19115524
[TBL] [Abstract][Full Text] [Related]
14. Hereditary Endocrine Tumors and Associated Syndromes: A Narrative Review for Endocrinologists and Endocrine Surgeons.
Moore EC; Ioannou L; Ruseckaite R; Serpell J; Ahern S
Endocr Pract; 2021 Nov; 27(11):1165-1174. PubMed ID: 34265452
[TBL] [Abstract][Full Text] [Related]
15. [Cytokine therapy and the endocrine system: is it necessary to monitor more than the thyroid gland?].
Schuppert F; Müller-Kunert E; Stöcker W; Bokemeyer C; Schmoll HJ; von zur Mühlen A; Rambusch EG
Med Klin (Munich); 1996 Feb; 91(2):59-65. PubMed ID: 8850099
[TBL] [Abstract][Full Text] [Related]
16. A clinicopathologic study of 1,047 cases of salivary gland tumors in Thailand.
Juengsomjit R; Lapthanasupkul P; Poomsawat S; Larbcharoensub N
Quintessence Int; 2015 Sep; 46(8):707-16. PubMed ID: 25328924
[TBL] [Abstract][Full Text] [Related]
17. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Salivary Gland Tumors.
Seethala RR; Griffith CC
Surg Pathol Clin; 2016 Sep; 9(3):339-52. PubMed ID: 27523965
[TBL] [Abstract][Full Text] [Related]
18. Applications of Immunohistochemistry to Endocrine Pathology.
Higgins SE; Barletta JA
Adv Anat Pathol; 2018 Nov; 25(6):413-429. PubMed ID: 30157042
[TBL] [Abstract][Full Text] [Related]
19. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
[TBL] [Abstract][Full Text] [Related]
20. Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations.
Gong J; Blais EM; Bender JR; Guan M; Placencio-Hickok V; Petricoin EF; Pishvaian MJ; Gregory G; Tuli R; Hendifar AE
Oncotarget; 2019 Oct; 10(58):6260-6268. PubMed ID: 31692857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
